A new HLA-B44 variant (B44BO [B(*)4408]) identified by serology

Tissue Antigens

Volumn 50, Issue 1, 1997, Pages 32-37

  Darke, C ^a,c   Street, J ^a   Fussell, H ^a   Thomas, M ^a   Guttridge, M ^a   Goldberg, T E ^a   Arnett, K L ^b   Parham, P ^b  

^a Regional Tissue Typing Laboratory   (United Kingdom)

^b STANFORD UNIVERSITY   (United States)

^c Welsh Blood Service   (United Kingdom)

Author keywords

HLA serology; HLA B(*)4408; HLA B44; New variant

Indexed keywords

ANTIBODY; HLA B ANTIGEN; NUCLEOTIDE;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; EXON; FAMILY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEROLOGY;

EID: 0030906240     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02830.x     Document Type: Article

References (46)

1. Kissmeyer-Nielsen F, Staub-Nielsen L, Lindholm A, Sandberg L, Svejgaard A, Thorsby E. The HL-A system in relation to human transplantation. In: Terasaki PI, ed. Histocompatibility testing 1970. Copenhagen: Munksgaard, 1970: 105-35.
2. Svejgaard A, Kissmeyer-Nielsen F, Thorsby E. HL-A typing of platelets. In: Terasaki PI, ed. Histocompatibility testing 1970. Copenhagen: Munksgaard, 1970: 153-64.
3. Richiardi P, Castegneto M, D'Amaro J, Schreuder I, Vassalli P, Curtoni ES. Four new HL-A allelic factors subtypic to HL-A12 and W15. Their correlation with W4 and W6. J Immunogenet 1974: 1: 323-35.
4. Williams RC, Chen SN, Gill DK, Lane JT et al. Antigen Society #6 report (B21, B49, Bw50, BN21, B12, B44, B45). In: Dupont B, ed. Immunobiology of HLA. Histocompatibility testing 1987. New York: Springer-Verlag, 1989: 1: 133-47.
5. Williams RC, Chen S, McAuley JE et al. W2.10 Antigen Society no. 106: HLA-B21, -B49, -B50, -B4005 (BN21), - B12, -B44, -B45. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. New York: Oxford University Press, 1992: 1: 305-8.
6. Tekolf WA, Biddison WE, Aster RD, Shaw S. Two subgroups of HLA-Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium. J Immunol 1982: 129: 1474-8.
7. Hahn AWA, Schendel DJ, Hansen PW, Ploegh HL. Biochemical and cellular identification of HLA-Bw44 subtypes. Hum Immunol 1984: 11: 69-76.
8. Rufer N, Breur-Vriesendorp BS, Tiercy J-M et al. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs: analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectric focusing, and HLA oligotyping. Hum Immunol 1993: 38: 235-9.
9. Yang SY. Population analysis of class I HLA antigens by one- dimensional isoelectric focusing gel electrophoresis: workshop summary report. In: Dupont B, ed. Immunobiology of HLA. Histocompatibility testing 1987. New York: Springer-Verlag, 1989: 1: 309-31.
10. Fleischhauer K, Kernan NA, Dupont B, Yang SY. The two major subtypes of HLA-B44 differ for a single amino acid in codon 156. Tissue Antigens 1991: 37: 133-7.
11. Petersdorf EW, Setoda T, Smith AG, Hansen JA. Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing. Tissue Antigens 1994: 44: 211-6.
12. Gauchat-Feiss D, Breur-Vriesendorp BS, Rufer N, Jeannet M, Roosnek E, Tiercy J-M. Sequencing of a novel functional HLA-B44 subtype differing in two residues in the alpha 2 domain. Tissue Antigens 1994: 44: 261-4.
13. Yao Z, Keller E, Scholz S, McNicholas A, Volgger A, Albert ED. Identification of two major HLA-B44 subtypes and a novel B44 sequence (B*4404) oligotyping and solid phase sequencing of polymerase chain reaction products. Hum Immunol 1995: 42: 54-60.
14. Vilches C, Sanz L, de Pablo R, Moreno ME, Puente S, Kreisler M. Molecular characterization of the new alleles HLA-B*8101 and B*4407. Tissue Antigens 1996: 47: 139-42.
15. Zhao W, Fernandez-Vina MA, Lazaro AM, Araujo HA, Miller S, Stastny P. Complete cDNA sequence of B*4406, an HLA-B allele containing sequences of B*5101 and B*4402. Tissue Antigens 1996: 47: 431-4.
16. Fleischhauer K, Avila D, Vilbois F, Traversari C, Bordignon C, Wallny H-J. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 1994: 44: 311-7.
17. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995: 46: 1-18.
18. Marsh SGE. Nomenclature for factors of the HLA system, update October 1995. Tissue Antigens 1996: 47: 90-1.
19. Street J, Fussell H, Thomas M, Darke C. HLA-B44BO - a possible variant of B44. Eur J Immunogenet 1995: 22: 136.
20. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, B, C, and D antigens. Am J Clin Pathol 1978: 69: 103-20.
21. Fussell H, Thomas M, Street J, Darke C. HLA-A9 antibodies and epitopes. Tissue Antigens 1996: 47: 307-12.
22. Darke C. The HLA-B12 and -B40 cross-reactive groups and their serological relationships. Tissue Antigens 1983: 21: 281-95.
23. Darke C. A serological study of the HLA-B17 cross-reactive group. Tissue Antigens 1984: 23: 141-50.
24. Milford EL, Park MS, Lalouel J-M, Kennedy LJ, Yunis EJ. Serologic exercises of the tenth workshop. In: Dupont B, ed. Immunobiology of HLA. Histocompatibility testing 1987. New York: Springer-Verlag, 1989: 1: 93-106.
25. Juji T, Akaza T, Miyoshi H, Kashiwase K. W2.2 Serum analysis at the Eleventh International Histocompatibility Workshop. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. New York: Oxford University Press, 1992: 1: 108-259.
26. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
27. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993: 41: 119-34.
28. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993: 90: 2842-5.
29. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence specific primers (PCR-SSP) Hum Immunol 1993: 37: 201-6.
30. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serologically and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994: 43: 7-17.
31. Bunce M, Fanning GC, Welsh KI. Comprehensive serological equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 45: 81-90.
32. Guttridge MG, Burr C, Klouda PT. Identification of HLA-B35, B53, B18, B5, B78 and B17 alleles by the polymerase chain reaction using sequence-specific primers (PCR-SSP). Tissue Antigens 1994: 44: 43-6.
33. Thomas M, Street J, Fussell H, Guttridge M, Darke C. Distribution of the HLA-A9 antigen family (A23, A24 and A2403). Tissue Antigens 1996: 48: 586-8.
34. Yang SY. A standardized method for the detection of HLA-A and HLA-B molecules by one-dimensional isoelectric focusing (IEF) gel electrophoresis. In: Dupont B, ed. Immunobiology of HLA. Histocompatibility testing 1987. New York: Springer-Verlag 1989: 1: 332-5.
35. Guttridge MG, Marsh SGE, Klouda PT. A new HLA-A2 variant (HLA-A2-SLU) identified by one-dimensional isoelectric focusing. Tissue Antigens 1992: 39: 32-4.
36. Domena JD, Little A-M, Madrigal AJ et al. Structural heterogeneity in HLA-B70, a high frequency antigen of black populations. Tissue Antigens 1993: 42: 509-17.
37. Parham P, Adams EJ, Arnett KL. The origins of HLA-A,B,C polymorphism. Immunol Rev 1995: 143: 141-80.
38. Darke C, Fussell H, Street J, Thomas M, Guttridge MG, Worwood M. Serological and molecular identification of an HLA-B8 variant - HLA-B8Jon [B*0802]. Exp Clin Immunogenet (in press).
39. Little A-M, Parham P. The HLA-Bw75 subtype of B15: molecular characterization and comparison with cross-reacting antigens. Tissue Antigens 1991: 38: 186-90.
40. Hildebrand WH, Madrigal JA, Belich MP et al. Serological cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups: dominant epitopes of the α2 helix. J Immunol 1992: 149: 3563-8.
41. Nisperos BB, Chung KH, Hansen JA, et al. W2.12 Antigen Society no. 108: HLA-B15, -B62, -B63, -B75, -B76, -B77, - B46. In: Tsuji K, Aizawa M, Sasazuki, T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol. 1. New York: Oxford University Press, 1991: 310-5.
42. Hildebrand WH, Domena JD, Shen SY et al. HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens 1994: 43: 209-18.
43. Darke C. A reanalysis of the HLA-B7 cross-reactive group. Tissue Antigens 1983: 22: 326-334.
44. Darke C. The first example of an HLA-Bw45 antiserum produced in a HLA-Bw44 positive woman. Tissue Antigens 1980: 15: 75-80.
45. Svejgaard A. Synergistic action of HL-A isoantibodies. Nature 1969: 222: 94-5.
46. Ahrons S, Thorsby E. Cytotoxic HL-A antibodies. Studies of synergism and gene-dose effect. Vox Sang 1970: 18: 323-33.